sodium citrate, anhydrous has been researched along with Deep Vein Thrombosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Appleton, D; Bhola, C; Khoo, B; Lok, CE; Richardson, RM | 1 |
Salvo, C | 1 |
Keeney, M; Kovacs, MJ; MacKinnon, K; Morrow, B; Payne, S | 1 |
Grudzinski, L; Kwok, S; Pierratos, A; Quinan, P | 1 |
4 other study(ies) available for sodium citrate, anhydrous and Deep Vein Thrombosis
Article | Year |
---|---|
Trisodium citrate 4%--an alternative to heparin capping of haemodialysis catheters.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Catheters, Indwelling; Citrates; Cost-Benefit Analysis; Female; Follow-Up Studies; Heparin; Humans; Incidence; Male; Middle Aged; Ontario; Prospective Studies; Renal Replacement Therapy; Venous Thrombosis | 2007 |
[Citrate locking solution for central venous catheters].
Topics: Anticoagulants; Catheterization, Central Venous; Catheters, Indwelling; Citrates; Humans; Sodium Citrate; Venous Thrombosis | 2014 |
Effect of 3.2 vs. 3.8% sodium citrate concentration on anti-Xa levels for patients on therapeutic low molecular weight heparin.
Topics: Anticoagulants; Blood Coagulation Tests; Citrates; Dalteparin; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Sodium Citrate; Venous Thrombosis | 2003 |
Sodium citrate 4% locking solution for central venous dialysis catheters--an effective, more cost-efficient alternative to heparin.
Topics: Aged; Anticoagulants; Buffers; Catheterization, Central Venous; Citrates; Cost-Benefit Analysis; Follow-Up Studies; Heparin; Humans; Prosthesis Failure; Renal Replacement Therapy; Retrospective Studies; Sodium Citrate; Venous Thrombosis | 2007 |